S1P helps ID location of pituitary gland tumors in Cushing's: Study
Levels of the molecule S1P in Cushing's were found to help identify pituitary gland tumor location and to predict remission after surgery.| Cushing's Disease News
Description This model is a BioBERT based sentence classification model that can determine whether the clinical sentences include terms related to biomarkers or not. Predicted Entities 1: Contains biomarker related terms, 0: Doesn't contain biomarker related terms Live Demo Open in Colab Download Copy S3 URI How to use PythonHealthcare NLPPythonJohnSnowLabsScalaNLU document_assembler = DocumentAssembler() \ .setInputCol("text") \ .setOutputCol("document") tokenizer = Tokenizer() \ .setInputCo...| Spark NLP
The activity of an immune-regulating protein is significantly lower just before or during a relapse in people with neuromyelitis optica spectrum disorder (NMOSD), a recent study has found. This discovery could lead to new ways to monitor disease activity and develop treatments. The protein, called the aryl hydrocarbon receptor (AHR), is a ligand-activated transcription factor. […] The post AHR protein may be a biomarker for NMOSD relapses appeared first on Neuromyelitis News.| Neuromyelitis News – The Web's Daily Resource for Neuromyelitis Optica News
Immune B-cells that contain the receptor protein CD226 may play a role in the development and clinical manifestations of primary Sjögren’s disease, making CD226 a possible target for future treatments, a study reports. Data indicated that people with Sjögren’s had proportionally more CD226-positive B-cells in their bloodstream than their healthy counterparts. The prevalence of these […] The post B-cells containing CD226 may be Sjögren’s biomarker, therapy target appeared first on S...| Sjogren's Disease News – The Web's Daily Resource for Sjogren's Disease News
Levels of the molecule S1P in Cushing's were found to help identify pituitary gland tumor location and to predict remission after surgery.| Cushing's Disease News
Blood levels of anti-AQP5 antibodies may be used as a biomarker to diagnose primary Sjögren’s disease, according to a new study from China.| Sjogren's Syndrome News
In a study, low TTR blood levels correlated with higher markers of inflammation, low BMI, and higher primary Sjögren's disease activity.| Sjogren's Syndrome News
Levels of GFAP in cerebrospinal fluid (CSF) may be a marker of Huntington’s disease progression, a study found.| Huntington's Disease News
A U.S. study shows that repeated sampling of hair follicles in people with fragile X syndrome can be used to measure FMRP protein levels.| Fragile X News Today
A photo-detection method can measure lactoferrin in dry eye disease patients' tears, making it a possible biomarker of disease severity.| Sjogren's Syndrome News
Primary Sjögren’s patients with extra-glandular symptoms have higher CXCL9 levels than those whose disease affects the saliva and tear glands.| Sjogren's Syndrome News
